Evidence map›Paper›PMID 32430684›Full record

ArticleCancer causes & control : CCC2020

Metabolomics profiling of visceral and abdominal subcutaneous adipose tissue in colorectal cancer patients: results from the ColoCare study.

Jennifer Ose, Andreana N Holowatyj, Johanna Nattenmüller, Biljana Gigic, Tengda Lin, Caroline Himbert, Nina Habermann, David Achaintre, Augustin Scalbert, Pekka Keski-Rahkonen and 10 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02328677 (ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Histologic and Racial/Ethnic Patterns of Appendiceal Cancer among Young Patients.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 6 countries.

Jennifer OseHuntsman Cancer Institute, Salt Lake City, UT, USA. jennifer.ose@hci.utah.edu.ORCID http://orcid.org/0000-0002-2030-9676
Andreana N HolowatyjHuntsman Cancer Institute, Salt Lake City, UT, USA.
Johanna NattenmüllerDiagnostic and Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany.
Biljana GigicDepartment of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Heidelberg, Germany.
Tengda LinHuntsman Cancer Institute, Salt Lake City, UT, USA.
Caroline HimbertHuntsman Cancer Institute, Salt Lake City, UT, USA.
Nina HabermannGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
David AchaintreInternational Agency Research on Cancer (IARC), Lyon, France.
Augustin ScalbertInternational Agency Research on Cancer (IARC), Lyon, France.
Pekka Keski-RahkonenInternational Agency Research on Cancer (IARC), Lyon, France.
Jürgen BöhmHuntsman Cancer Institute, Salt Lake City, UT, USA.
Petra Schrotz-KingDivision of Preventive Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Martin SchneiderDepartment of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Heidelberg, Germany.
Alexis UlrichDepartment of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Heidelberg, Germany.
Ellen KampmanDivision of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
Matty WeijenbergDepartment of Epidemiology, GROW - School of Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Andrea GsurInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Per-Magne UelandBEVITAL, Bergen, Norway.
Hans-Ulrich KauczorDiagnostic and Interventional Radiology, University Hospital of Heidelberg, Heidelberg, Germany.
Cornelia M UlrichHuntsman Cancer Institute, Salt Lake City, UT, USA. neli.ulrich@hci.utah.edu.
Heidelberg University · DEUniversity of Utah · USCentre international de recherche sur le cancer · FRHuntsman Cancer Institute · USBevital (Norway) · NOEuropean Molecular Biology Laboratory · DEGerman Cancer Research Center · DEMaastricht University · NLMedical University of Vienna · ATWageningen University & Research · NL

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
Discovery and verification of novel biomarkers of colorectal cancer recurrenceR01CA189184 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2015 to 2020
$5.6M
Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer RecurrenceR01CA207371 · NCI · UNIVERSITY OF UTAH · PI LI, CHRISTOPHER I, ULRICH, CORNELIA M · 2017 to 2022
$3.9M
Training Program in Genomic MedicineT32HG008962 · NHGRI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Lynn Jorde, Aaron R Quinlan · 2016 to 2026
$3.0M
NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA189184NCI NIH HHS R01 CA207371NCI NIH HHS U01 CA206110NHGRI NIH HHS T32 HG008962World Health Organization 001ZonMw UW2013-6397
6 · The paper itself

Abstract

purposeUnderlying mechanisms of the relationship between body fatness and colorectal cancer remain unclear. This study investigated associations of circulating metabolites with visceral (VFA), abdominal subcutaneous (SFA), and total fat area (TFA) in colorectal cancer patients.

methodsPre-surgery plasma samples from 212 patients (stage I-IV) from the ColoCare Study were used to perform targeted metabolomics. VFA, SFA, and TFA were quantified by computed tomography scans. Partial correlation and linear regression analyses of VFA, SFA, and TFA with metabolites were computed and corrected for multiple testing. Cox proportional hazards were used to assess 2-year survival.

resultsIn patients with metastatic tumors, SFA and TFA were statistically significantly inversely associated with 16 glycerophospholipids (SFA: p

conclusionThese data provide initial evidence that glycerophospholipids in metastatic colorectal cancer are uniquely associated with subcutaneous adiposity, and may impact overall survival.

Indexed as

AdiposityAdolescentAdultAgedAged, 80 and overBody Mass IndexColorectal NeoplasmsFemaleHumansIntra-Abdominal FatMaleMetabolomicsMiddle AgedNeoplasm StagingSubcutaneous Fat, AbdominalTomography, X-Ray ComputedAdipose tissueColorectal cancerGlycerophospholipidsSurvival

Identifiers

PMID32430684
PMCPMC7425810
OpenAlexW3026034884

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.